bioAffinity Technologies, Inc.(BIAF)

Medical - Diagnostics & Research · San Antonio, TX

$6.19+0.14 (+2.23%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

bioAffinity Technologies (BIAF) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T12:50:42.177Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:50:42.177Z.

Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 6.19
Unrounded diluted TTM EPS · period ending 2026-06-30: -120.15

FMP input reference: b8a0cb47064437e8b9c77c3ec53eeb060705b9d611480c07f1c1fa4a72564033

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

BIAF PE Ratio Metrics

PE RATIO

N/A

BIAF Competitors' PE Ratio

BIAF

bioAffinity Technologies, Inc.

Current

Market Cap

$2.59M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBLG

FibroBiologics, Inc. Common Stock

vs BIAF

Market Cap

$2.47M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs BIAF

Market Cap

$2.37M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs BIAF

Market Cap

$2.36M

PE Ratio

N/A

TTM Avg

98120994617.14

3Y Avg

98120994617.14

5Y Avg

98120994617.14

BRTX

BioRestorative Therapies, Inc.

vs BIAF

Market Cap

$3.09M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADGM

Adagio Medical Holdings, Inc.

vs BIAF

Market Cap

$3.13M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMIX

Autonomix Medical, Inc.

vs BIAF

Market Cap

$1.92M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CVKD

Cadrenal Therapeutics, Inc. Common Stock

vs BIAF

Market Cap

$3.37M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AEMD

Aethlon Medical, Inc.

vs BIAF

Market Cap

$3.44M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ICCM

IceCure Medical Ltd

vs BIAF

Market Cap

$3.47M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
bioAffinity Technologies, Inc. (BIAF)	$2.59M	N/A	N/A	N/A	N/A
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.47M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.37M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.36M	N/A	98120994617.14	98120994617.14	98120994617.14
BioRestorative Therapies, Inc. (BRTX)vs ›	$3.09M	N/A	N/A	N/A	N/A
Adagio Medical Holdings, Inc. (ADGM)vs ›	$3.13M	N/A	N/A	N/A	N/A
Autonomix Medical, Inc. (AMIX)vs ›	$1.92M	N/A	N/A	N/A	N/A
Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›	$3.37M	N/A	N/A	N/A	N/A
Aethlon Medical, Inc. (AEMD)vs ›	$3.44M	N/A	N/A	N/A	N/A
IceCure Medical Ltd (ICCM)vs ›	$3.47M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$6.19

Forward EPS (Est.)

$-121.50

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

BIAF PE Ratio Metrics

BIAF Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics